طباعة نظرة عامةAn epithelioid hemangioendothelioma (EHE) is a rare cancer called a vascular sarcoma. It typically starts in cells called endothelial cells. These cells line blood vessels. They can form almost anywhere in the body. Common areas include the liver, lungs, soft tissue and bones. EHE is part of the sarcoma family of cancers. It is not the same as an angiosarcoma, even though the two cancers can look alike under a microscope. EHE can happen at any age. It most often is diagnosed in middle-aged adults. It is very rare in children. EHE can act differently from one person to another. Some EHE tumors may grow slowly for years. Other EHE tumors may grow quickly. Treatment depends on where the EHE is located, whether it causes symptoms and whether it has spread to other parts of the body. الأعراضEHE does not always cause symptoms. Sometimes EHE tumors are found on scans done for another reason. EHE symptoms can vary based on where the tumor is in the body. Symptoms in these areas may include: Lungs: Cough, chest pain, or shortness of breath. Liver: Large tumors may cause pain or discomfort in the belly area. Soft tissues: A lump or pain. Bones: Swelling, pain or broken bone. When to see a doctor Make an appointment with a healthcare professional if you have symptoms that worry you or are not going away. طلب تحديد موعد الأسبابThe cause of EHE is not known. Researchers found certain gene changes in EHE tumor cells, but it’s not clear what causes these gene changes to happen. عوامل الخطورةThe risk factors for EHE are not known. المضاعفاتEHE complications may include: Tumor spread, also called metastasis, within an organ or to other parts of the body. Fluid buildup around the lungs or in the belly. الوقايةResearchers do not know what causes EHE. Factors that may increase a person's risk of developing EHE are not known. Epithelioid hemangioendothelioma (EHE) - الرعاية في Mayo Clinic (مايو كلينك) طلب تحديد موعد التشخيص والعلاج 02/09/2026 طباعةإظهار المَراجع Beretta A, et al. Translating molecular mechanisms of epithelioid hemangioendothelioma to improve patient outcome. Critical Reviews in Oncology/Hematology. 2026; doi:10.1016/j.critrevonc.2025.105021. Haughey AM, et al. Epithelioid haemangioendothelioma; not simply a hepatic pathology. Clinical Imaging. 2023; doi:10.1016/j.clinimag.2023.07.003. Weadick CS, et al. Incidence, prevalence and treatment of patients with epithelioid haemangioendothelioma (EHE) in Canada: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) and Multi-pronged Canadian Research in Epithelioid Haemangioendothelioma (PRO_CARE EHE) study. European Journal of Cancer. 2025; doi:10.1016/j.ejca.2025.116100. Stacchiotti S, et al. Epithelioid hemangioendothelioma, an ultra-rare cancer: A consensus paper from the community of experts. ESMO Open. 2021; doi:10.1016/j.esmoop.2021.100170. Blay JY, et al. Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years. European Journal of Cancer. 2023; doi:10.1016/j.ejca.2023.113262. Orbach D, et al. Epithelioid hemangioendothelioma in children: The European Pediatric Soft Tissue Sarcoma Study Group experience. Pediatric Blood & Cancer. 2022; doi:10.1002/pbc.29882. Paulson KG, et al. Incidence, demographics, and survival of malignant hemangioendothelioma in the United States. Cancer Medicine. 2023; doi:10.1002/cam4.6181. Tang B, et al. Pulmonary epithelioid haemangioendothelioma: A comprehensive review of clinical and molecular advances. Clinics. 2025; doi:10.1016/j.clinsp.2025.100789. Pimenta EM, et al. Epithelioid hemangioendothelioma: Treatment landscape and innovations for an ultra-rare sarcoma. Current Treatment Options in Oncology. 2025; doi:10.1007/s11864-025-01328-2. Burkhard-Meier A, et al. First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: A retrospective single-center analysis. Journal of Cancer Research and Clinical Oncology. 2025; doi:10.1007/s00432-025-06208-8. Salerno KE, et al. Radiation therapy for treatment of soft tissue sarcoma in adults: Executive summary of an ASTRO clinical practice guideline. Practical Radiation Oncology. 2021; doi:10.1016/j.prro.2021.04.005. Sanders JJ, et al. Palliative care for patients with cancer: ASCO guideline update. Journal of Clinical Oncology. 2024; doi:10.1200/JCO.24.00542. ذات صلة الإجراءات الطبية ذات الصلة التصوير المقطعي بالإصدار البوزيتروني (PET) التصوير بالرنين المغناطيسي (MRI) الرعاية التلطيفية العلاج الإشعاعي العلاج الكيميائي الفحص بالتصوير المقطعي المحوسب خزعة بالإبرة علاج السرطان أظهر المزيد من الإجراءات ذات الصلة Epithelioid hemangioendothelioma (EHE)الأعراضوالأسبابالتشخيصوالعلاجالأطباءوالأقسامالرعاية فيMayoClinic Advertisement لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية. الإعلان والرعاية البوليصة فرص الإعلان خيارات الإعلان Mayo Clinic Press تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press. جديد: دليل مايو كلينيك لتحسين جودة النوم استمع إلى البث الصوتي: Health Matters توصيات مايو كلينك بشأن السلس كتاب أساسيّات السكري تقييم النظام الغذائي المجاني من مايو كلينك خطاب مايو كلينك الصحي — كتاب مجاني CON-20604916 الأمراض والحالات Epithelioid hemangioendothelioma (EHE)